For their weight loss program, the company provides patients with access to FDA-approved weight loss medications, a dedicated insurance concierge, ongoing provider support, and health coaching
ACS Pharmacol
GLP2 once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): A double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
Researchers specifically targeting visceral and hepatic fat may find this advantage decisive in their compound selection
First, engage with our team through a personalized online consultation with an experienced healthcare provider who will develop a customized treatment plan reflecting your health aspirations
Pancreatitis: Though rare, there is a potential risk of pancreatitis, a serious condition involving inflammation of the pancreas